MADISON – Exact Sciences shares inch lower after earnings, stock sale reports

Shares of Exact Sciences Corp. stock slid 7 percent on Tuesday after the Madison company announced a wider loss in its quarterly earnings report along with plans to sell more shares.

The stock closed at $25.15, down $1.88. But at least two analysts issued upbeat notes, reiterating their projections that shares will rise to the mid-$30 range for the maker of the Cologuard non-invasive DNA test for colorectal cancer.

Read more.

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display